News

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced the continuation of their collaboration with Zymeworks Inc. Applied BioMath will design and deliver a systems pharmacology model...

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating...

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced the enrollment of its first COVID-19 patient in the Company's ongoing Phase 3 clinical trial of AR-301,...

Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected with COVID-19. The partnership will assess the benefit of INOmax (nitric oxide) gas in mechanically...

Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate AJICAP, a site-specific conjugation technology offered by Aji Bio-Pharma for the development of TRIObody Drug...

Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivir at additional hospitals across...

Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19 future. Following the drastic social distancing measures implemented across the world, Inspirata announced its COVID-19 Free Remote Pathology Initiative in March, which allows healthcare institutions...